Carprogesic 100mg Tablets for Dogs
Country: Ireland
Language: English
Source: HMA (Heads of Medicines Agencies)
Summary of Product characteristics
(SPC)
21-08-2013
Some documents for this product are not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain them.
Send request.
Send request.
Active ingredient:
carprofen 100 mg
Available from:
Norbrook Laboratories Limited
ATC code:
QM01AE91
Pharmaceutical form:
Tablet
Therapeutic group:
carprofen
Therapeutic area:
Dogs
Authorization date:
2009-03-23
Summary of Product characteristics
5/08/09
AN: 02476/2007
SUMMARY OF PRODUCT CHARACTERISTICS
1.
NAME OF THE VETERINARY MEDICINAL PRODUCT
Carprogesic 100mg Tablets for Dogs.
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
Each tablet contains:
Active Ingredient:
Carprofen
100 mg
Excipients:
Tartrazine (E102)
1.2 mg
For a full list of excipients see Section 6.1
3.
PHARMACEUTICAL FORM
Tablet
A yellow circular tablet of 8 mm diameter, 100 embossed on one side and a single
breakline on the other side.
The tablets can be divided into equal halves.
4.
CLINICAL PARTICULARS
4.1
_TARGET SPECIES:_
Dogs
4.2
_INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES:_
In the dog:
Reduction of inflammation and pain caused by musculoskeletal disorders and
degenerative joint disease. As a follow up to parenteral analgesia in the management
of post operative pain.
4.3
_CONTRAINDICATIONS:_
Do not use in cats.
Do not use in pregnant or lactating bitches.
Do not use in puppies less than 4
months of age.
Do not use in case of hypersensitivity to
active substance or to any of the excipients.
Do not use in dogs suffering from cardiac, hepatic or renal disease, where there is a
possibility of gastrointestinal ulceration or bleeding, or where there is evidence of a
blood dyscrasia.
5/08/09
AN: 02476/2007
4.4
_SPECIAL WARNINGS FOR EACH TARGET SPECIES:_
Refer to Sections 4.3 and 4.5.
4.5
_SPECIAL PRECAUTIONS FOR USE:_
SPECIAL PRECAUTIONS FOR USE IN ANIMALS
Use
Read the complete document
